Financhill
Back

Galectin Therapeutics Stock Predictions

Galectin Therapeutics Stock Forecast

  • Is Galectin Therapeutics Stock Undervalued?
    The current Galectin Therapeutics [GALT] share price is $1.03. The Score for GALT is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
  • GALT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Galectin Therapeutics Stock Go Up Next Year?

Data Unavailable

Galectin Therapeutics Stock Rating

Data Unavailable

Galectin Therapeutics Stock Price History

Is GALT stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GALT is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
galectintherapeutics.com

52-Week Data

52-Week High:
4.27
52-Week Low:
0.73

Prediction Charts

Market Cap:
64.6M
Price in USD:
1.03
Volume:
9.2M
Beta:
1.19

Technical Analysis

SMA50:
2.51
SMA100:
2.51
SMA200:
2.64
52-Wk Change:
-39.77%

Stock Predictions

  • Is Galectin Therapeutics stock public?
    Yes, Galectin Therapeutics is a publicly traded company.
  • What is the Galectin Therapeutics stock quote today?
    The Galectin Therapeutics stock price is 1.03 USD today.
  • How to buy Galectin Therapeutics stock online?
    You can buy Galectin Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-3 2.80 2.60 2.81 2.58
Dec-4 2.54 2.36 2.59 2.30
Dec-5 2.42 2.11 2.46 2.10
Dec-6 2.00 2.05 2.25 2.00
Dec-9 2.03 1.91 2.09 1.80
Dec-10 1.91 1.93 2.00 1.84
Dec-11 1.95 1.95 2.00 1.86
Dec-12 1.96 1.99 2.03 1.91
Dec-13 1.97 2.11 2.20 1.96
Dec-16 2.20 2.31 2.36 2.12
Dec-17 2.32 2.12 2.32 1.99
Dec-18 2.12 2.02 2.15 1.97
Dec-19 2.02 2.00 2.11 1.90
Dec-20 1.18 1.03 1.50 0.73

Galectin Therapeutics Earnings

Data Unavailable

Galectin Therapeutics Forecast Revenue Growth

Data Unavailable

* Galectin Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.